As of 8 July 2020, there have been 11,635,939 confirmed cases of COVID-19, including 539,026 deaths, worldwide.
As healthcare systems around the world work to deal with the influx of COVID-19 cases, continuing HIV testing services and treatment has never been more important. In order to maintain health services, including HIV services, the role of HIV self-testing in the COVID-19 context may be an acceptable alternative to maintain services while also adhering to physical distancing guidance.
In this two-part webinar series, STAR and partners explored other modifications that would enable the continuation of HIV testing and treatment services such as offering HIVST at pick up points outside of the health care facilities, or the distribution of HIVST through independent community pharmacies.
The first webinar, Considerations for HIVST in the context of COVID-19, explored case studies from South Africa, eSwatini and Kenya providing an overview of ways that service providers, implementers and country governments can pivot towards HIVST during the COVID-19 pandemic. The second webinar in the series focused on Strategic Leveraging of HIVST in the COVID-19 Pandemic for key populations and vulnerable population groups with case studies from Vietnam, Ukraine, Zambia and West Africa as we discussed how to adapt HIV programming during this pandemic.
Some questions that we explored:
- What has worked in each of these countries?
- What gaps have we seen during this time?
- What is the way forward?
Want to learn more? Dive into the full recordings below! And be sure to check out Unitaid’s STAR/ATLAS Technical Guide “Considerations for HIVST in the context of COVID-19″ for more information.
La version française du guide technique sera bientôt disponible en téléchargement.
Considerations for HIVST in the context of COVID-19:
Strategic Leveraging of HIVST in the COVID-19 Pandemic: